% | $
Quotes you view appear here for quick access.

Alnylam Pharmaceuticals, Inc. Message Board

  • drumss11 drumss11 Jul 18, 2013 1:09 PM Flag


    Insiders have been selling since February up thru July 12th. Michael Mason (VP) sold 14,000+ shares at
    $50 on July 12th. I was going to buy this stock on the latest pullback but will wait until the insiders come back in. IMO this could be around $35. Great potential in ALNY but not at the current price and I believe the run-
    up was overdone.

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • up !

      Sentiment: Sell

    • ALNY is just coming back to true value. After the July 11 Phase 1 press lots of people thought they saw a chance for a quick buck. Phase 1 announcements are worthless. No big pharma will look at contracting after just a Phase1 announcement. Not even after a Phase 2. ALNY will be dead in the water for at least a year and a half. In the meanwhile there are many rising stocks that did the rise on something other than a company pump, they did it on results. I wouldn't touch this stock with a ten foot pole until it is in the threes. Buy stocks on results, not on company pumps.

    • Your post does not make sense. "Great potential but not at the current price". If there is great potential then it will be way above its current price eventually.

      I hear what you are saying. You are saying that you think it will go lower. But let's be clear. If there is 'great potential' then it is a good buy right here. If there is not great potential, then why even buy @ $30?

    • you are spot on. i like the company. but compare it's valuation to isis and tkmr. overpriced. and heavy insider selling a red flag. i'll buy in the 30s if it drops that low.

72.02+0.46(+0.64%)12:20 PMEDT